	Delays in Medical Care Among Skin of Color Melanoma Patients: A Population-Based Study. J Drugs Dermatol Khan S, Jeong C, Zagona-Prizio C, Mehta MD, Maynard N, Reddy R, Yee D, Armstrong AW. PMID: 41931684 [PubMed - in process]
	Epigenetics of Malignant Melanoma: Mechanisms, Diagnostic Approaches and Therapeutic Applications. Oncol Res Hong SG, Murphy GF, Lian CG. PMID: 41930165 [PubMed - indexed for MEDLINE]
	Integrative bioinformatic and experimental analysis reveals prognostic and immunological roles of psychological stress-related genes in skin cutaneous melanoma. Clin Transl Oncol Zheng B, Ge Y. PMID: 41926057 [PubMed - as supplied by publisher]
	Correction to: Best foot forward: podiatrists' insight and awareness of melanoma of the foot-a questionnaire study. Skin Health Dis PMID: 41923958 [PubMed]
	Early detection of metastatic risk in primary cutaneous melanoma using weakly supervised learning. Sci Rep Dahlén F, Shujski I, Yacob F, Häggström I, Jovanovic J, Dudina O, Pölönen I, Neittaanmäki N. PMID: 41922451 [PubMed - in process]
	Autophagy meets tissue-resident memory: Emerging crosstalk and therapeutic opportunities in cutaneous melanoma. Biochim Biophys Acta Rev Cancer Toma B, Pavel-Tanasa M, Danciu M. PMID: 41921757 [PubMed - as supplied by publisher]
	Metabolic reprogramming-a breakthrough point in overcoming resistance to BRAF mutant melanoma targeted therapy (Review). Oncol Lett Zhao X, Chen F, Li H. PMID: 41918811 [PubMed]
	A Multitask Deep Learning Approach for Tumor Segmentation and Morphological Quantification in Acral Melanoma Whole-Slide Images. J Imaging Inform Med An X, Liu L, Liu M, Liu J. PMID: 41917244 [PubMed - as supplied by publisher]
	Risk of Subsequent Primary Melanoma in 68,002 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup cohort study. J Natl Cancer Inst Shojaie B, Teepen JC, Winter DL, Gardner MP, Kaiser M, Grabow D, Ronckers CM, Byrne J, Skinner R, Alessi D, Baqaeen H, Allodji RS, Van Der Pal HJ, Jankovic M, Bagnasco F, Steliarova-Foucher E, Spycher BD, Sommer G, Bárdi E, Gudmundsdottir T, Maule MM, Michel G, Muraca M, Gunnes MW, Kenborg L, Hjalgrim H, Sacerdote C, Jakab Z, Haupt R, Wiebe T, Terenziani M, Zaletel LZ, Kremer LCM, Kuehni CE, Lähteenmäki PM, De Vathaire F, Hjorth L, Hawkins MM, Reulen RC. PMID: 41915055 [PubMed - as supplied by publisher]
	Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma. Future Oncol Dummer R, Sandhu S, Miller WH Jr, Butler MO, Taylor MH, Heinzerling L, Blank CU, Couselo EM, Burris HA 3rd, Postow MA, Chmielowski B, Middleton MR, Berking C, Hassel JC, Gesierich AH, Mauch C, Kleha JF, Polli A, Harney AS, di Pietro A, Ascierto PA. PMID: 41914670 [PubMed - as supplied by publisher]
	Combination of Postoperative Adjuvant Chemoradiotherapy and Immune Checkpoint Inhibitors Significantly Prolongs Recurrence-Free Survival in Sinonasal Mucosal Melanoma. J Otolaryngol Head Neck Surg Ding Q, Wu J, Ding Y, Li D, Wen X, Jiang H, Chen L, Zhang Q, Zhang Y, Lu L, Zhang X, Li J. PMID: 41914622 [PubMed - indexed for MEDLINE]
	CLO26-079: Survival and Therapeutic Patterns in Melanoma: A Retrospective Study From a Tertiary Referral Center in Northern Mexico. J Natl Compr Canc Netw Hernandez TO, Lagunes MLR, Devora DAR. PMID: 41911906 [PubMed - in process]
	CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II Trial. J Natl Compr Canc Netw Borgers JSW, Wu CC, Medina TM, Muckle CM, Katsnelson EN, Whitty PA, Mantle L, Patel SP, Gao D, Jordan KR, Robinson WA, Tobin RP, Couts KL, McCarter MD. PMID: 41911891 [PubMed - in process]
	HSR26-199: Socioeconomic, Geographic, and Insurance-Related Disparities in Survival and Treatment Outcomes for Ocular Melanoma: A 21-Year National Inpatient Cohort Study. J Natl Compr Canc Netw Miller RM, Graham WE, Kang P, Graff J, Barakat MR. PMID: 41911777 [PubMed - in process]
	Microwave therapy for the treatment of cutaneous melanoma metastases - A pilot study. J Eur Acad Dermatol Venereol O'Driscoll D, Losol P, Pulido AV, von Witzleben A, Boukas K, Sommerlad M, Ottensmeier C, Ardern-Jones MR. PMID: 41910004 [PubMed - as supplied by publisher]
	Conceptual proposal for LLM-generated FDG PET/CT follow-up reports in melanoma: a pilot study on model stability and blinded expert evaluation. Front Nucl Med Bosbach WA, Heide MS, Gözlügöl N, Fatemeh D, Aghapour Zangeneh F, Ventura D, Schindler P, Roll W, Strunz F, Caobelli F, Shi K, Afshar-Oromieh A, Rominger A, Seifert R. PMID: 41909529 [PubMed]
	Reflectance confocal microscopy in the management of lentigo maligna and lentigo maligna melanoma: a systematic review. JPRAS Open Mathieu O, Henderson D, Ezine E, Serror K, Baroudjian B, Battistella M, Lebbé C, Chaouat M, Boccara D. PMID: 41908627 [PubMed]
	Phytochemicals with epigenetic properties and their role in melanoma therapy. Int Rev Cell Mol Biol Anestopoulos I, Kyriakou S, Deligiorgi MV, Trafalis DT, Botaitis S, Giatromanolaki AN, Franco R, Koukourakis MI, Pappa A, Panayiotidis MI. PMID: 41905784 [PubMed - indexed for MEDLINE]
	Response-Based Immunotherapy in Melanoma: A New Paradigm. Surg Oncol Clin N Am Bushara O, Farooq MS, Vargas G, Karakousis G. PMID: 41903986 [PubMed - indexed for MEDLINE]
	Advantages of MelArray over Oncomine Focus Assay for Mutation Analysis in Melanoma. Medicina (Kaunas) Quacoe AE, Freiberger SN, Levesque MP, Dummer R, Ramelyte E. PMID: 41901593 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 45405

Page 1 of 2271



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy